Published in J Biol Chem on October 01, 2001
Metabolic basis of visual cycle inhibition by retinoid and nonretinoid compounds in the vertebrate retina. J Biol Chem (2008) 1.51
Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans. J Clin Invest (2007) 1.29
Inhibitors of protein geranylgeranyltransferase I and Rab geranylgeranyltransferase identified from a library of allenoate-derived compounds. J Biol Chem (2008) 1.23
The regulation of osteoclast function and bone resorption by small GTPases. Small GTPases (2011) 1.11
Rab3D regulates a novel vesicular trafficking pathway that is required for osteoclastic bone resorption. Mol Cell Biol (2005) 1.08
Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities. Clin Genet (2011) 1.05
Novel functions for Rab GTPases in multiple aspects of tumour progression. Biochem Soc Trans (2012) 1.04
Isoprenoid biosynthetic pathway inhibition disrupts monoclonal protein secretion and induces the unfolded protein response pathway in multiple myeloma cells. Leuk Res (2010) 1.03
Triazole-based inhibitors of geranylgeranyltransferase II. Bioorg Med Chem Lett (2012) 1.01
The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts. Bone (2009) 0.99
Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections. Medchemcomm (2013) 0.97
Phosphonocarboxylates inhibit the second geranylgeranyl addition by Rab geranylgeranyl transferase. J Biol Chem (2008) 0.96
RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro. Arthritis Res Ther (2009) 0.91
Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease. Pharmacol Ther (2014) 0.90
Genetic ablation of CD68 results in mice with increased bone and dysfunctional osteoclasts. PLoS One (2011) 0.90
Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro. Br J Pharmacol (2012) 0.83
Targeting HSP90 and monoclonal protein trafficking modulates the unfolded protein response, chaperone regulation and apoptosis in myeloma cells. Blood Cancer J (2013) 0.81
Rab13 is upregulated during osteoclast differentiation and associates with small vesicles revealing polarized distribution in resorbing cells. J Histochem Cytochem (2012) 0.81
Farnesyl pyrophosphate synthase modulators: a patent review (2006 - 2010). Expert Opin Ther Pat (2011) 0.79
Mechanisms for autophagy modulation by isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells. Oncotarget (2015) 0.79
Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells. Breast Cancer Res (2008) 0.79
Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Pharmacol Exp Ther (2007) 0.79
Impaired prenylation of Rab GTPases in the gunmetal mouse causes defects in bone cell function. Small GTPases (2011) 0.78
Induction of creatine kinase release from cultured osteoclasts via the pharmacological action of aminobisphosphonates. Springerplus (2015) 0.77
N-Oxide derivatives of 3-(3-pyridyl)-2-phosphonopropanoic acids as potential inhibitors of Rab geranylgeranylation. Bioorg Med Chem Lett (2015) 0.77
Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases. Immunol Cell Biol (2016) 0.77
Evolutionary comparison of prenylation pathway in kinetoplastid Leishmania and its sister Leptomonas. BMC Evol Biol (2015) 0.75
The Roles of Small GTPases in Osteoclast Biology. Orthop Muscular Syst (2015) 0.75
Calmodulin interacts with Rab3D and modulates osteoclastic bone resorption. Sci Rep (2016) 0.75
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int (2008) 4.73
Evolution of the Rab family of small GTP-binding proteins. J Mol Biol (2001) 4.52
Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides. Cell (1990) 3.99
The mammalian Rab family of small GTPases: definition of family and subfamily sequence motifs suggests a mechanism for functional specificity in the Ras superfamily. J Mol Biol (2000) 3.75
Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res (1998) 3.65
Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther (2001) 3.59
Protein prenyltransferases. J Biol Chem (1996) 3.52
The melanosome: membrane dynamics in black and white. Nat Rev Mol Cell Biol (2001) 3.44
Computational and experimental characterization of physically clustered simple sequence repeats in plants. Genetics (2000) 3.39
Construction of the mycoplasma evolutionary tree from 5S rRNA sequence data. Proc Natl Acad Sci U S A (1985) 3.38
GTPase activity of Rab5 acts as a timer for endocytic membrane fusion. Nature (1996) 3.23
Purification and properties of rat liver microsomal stearyl coenzyme A desaturase. Proc Natl Acad Sci U S A (1974) 3.18
Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone (2005) 3.13
Utility of the sperm chromatin structure assay as a diagnostic and prognostic tool in the human fertility clinic. Hum Reprod (1999) 2.79
Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med (1997) 2.77
Rab27a regulates the peripheral distribution of melanosomes in melanocytes. J Cell Biol (2001) 2.76
Rab27a is required for regulated secretion in cytotoxic T lymphocytes. J Cell Biol (2001) 2.74
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci U S A (1999) 2.66
A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors. Int J Clin Pract (2010) 2.57
Bisphosphonates: from the laboratory to the clinic and back again. Bone (1999) 2.55
Monoclonal antibodies to osteoclastomas (giant cell bone tumors): definition of osteoclast-specific cellular antigens. Cancer Res (1985) 2.42
Anticodon and acceptor stem nucleotides in tRNA(Gln) are major recognition elements for E. coli glutaminyl-tRNA synthetase. Nature (1991) 2.39
A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J Clin Invest (1997) 2.37
Comparison of circumsporozoite proteins from avian and mammalian malarias: biological and phylogenetic implications. Proc Natl Acad Sci U S A (1996) 2.35
Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course. Pediatrics (1994) 2.33
Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. Cancer Res (2000) 2.32
Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J Immunol (1997) 2.30
A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med (1986) 2.26
EUR-ASSESS Project Subgroup Report on Dissemination and Impact. Int J Technol Assess Health Care (1997) 2.18
Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity. Br J Haematol (1997) 2.14
Isoprenylcysteine carboxyl methyltransferase deficiency in mice. J Biol Chem (2000) 2.09
cDNA cloning of component A of Rab geranylgeranyl transferase and demonstration of its role as a Rab escort protein. Cell (1993) 2.02
Addressing the challenges of the clinical application of pharmacogenetic testing. Clin Pharmacol Ther (2009) 1.99
Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en. Antimicrob Agents Chemother (1996) 1.94
Trafficking of matrix collagens through bone-resorbing osteoclasts. Science (1997) 1.93
The "Eve" decision: "it may turn out to be a meek authority indeed". CMAJ (1987) 1.92
Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann Intern Med (1988) 1.90
Rab escort protein-1 is a multifunctional protein that accompanies newly prenylated rab proteins to their target membranes. EMBO J (1994) 1.81
Plasmodium: genus-conserved primers for species identification and quantitation. Exp Parasitol (1995) 1.81
Single integrin molecule adhesion forces in intact cells measured by atomic force microscopy. Biochem Biophys Res Commun (1999) 1.74
Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res (1997) 1.72
The binding of cytochrome b 5 to liver microsomes. J Biol Chem (1972) 1.71
Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J Bone Miner Res (2000) 1.70
Specific encapsidation of nodavirus RNAs is mediated through the C terminus of capsid precursor protein alpha. J Virol (1998) 1.68
Detection of cytomegalovirus antibody with latex agglutination. J Clin Microbiol (1985) 1.66
The response to Medicare. Public Health Rep (1968) 1.63
REP-2, a Rab escort protein encoded by the choroideremia-like gene. J Biol Chem (1994) 1.62
Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp Cell Res (1991) 1.57
The cytoplasmic ribosomal RNAs of Plasmodium spp. Parasitol Today (1995) 1.56
Alternative responses to child protective services: emerging issues and concerns. Child Abuse Negl (2000) 1.53
Inhibition of Plasmodium falciparum protein synthesis. Targeting the plastid-like organelle with thiostrepton. J Biol Chem (1997) 1.51
Apoptosis induced by inhibition of intercellular contact. J Cell Biol (1994) 1.49
Lipid-protein interactions in the reconstitution of the microsomal reduced nicotinamide adenine dinucleotide-cytochrome b 5 reductase system. J Biol Chem (1973) 1.49
Rab geranylgeranyl transferase alpha mutation in the gunmetal mouse reduces Rab prenylation and platelet synthesis. Proc Natl Acad Sci U S A (2000) 1.48
Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs. Mol Pharmacol (1999) 1.48
Do surface plant and soil seed bank populations differ genetically? A multipopulation study of the desert mustard Lesquerella fendleri (Brassicaceae). Am J Bot (1998) 1.46
Apparent dependence of interactions between cytochrome b5 and cytochrome b5 reductase upon translational diffusion in dimyristoyl lecithin liposomes. Proc Natl Acad Sci U S A (1975) 1.46
A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol (1992) 1.45
Health in the 5th 5-years Development Plan of Iran: Main Challenges, General Policies and Strategies. Iran J Public Health (2013) 1.45
A Spiroplasma tRNA gene cluster. Isr J Med Sci (1984) 1.44
A synthesis of dominant ecological processes in intensive shrimp ponds and adjacent coastal environments in NE Australia. Mar Pollut Bull (2003) 1.44
Compartmental signal modulation: Endosomal phosphatidylinositol 3-phosphate controls endosome morphology and selective cargo sorting. Proc Natl Acad Sci U S A (2006) 1.43
A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: a novel mechanism of oncogene de-regulation. Oncogene (2000) 1.43
Failure of cells of the mononuclear phagocyte series to resorb bone. Calcif Tissue Int (1984) 1.43
In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell lines. Br J Cancer (1999) 1.42
Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis (1992) 1.42
Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices. Cancer Res (1997) 1.39
The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway. Cancer Res (1998) 1.39
Nitric oxide: a cytokine-induced regulator of bone resorption. J Bone Miner Res (1995) 1.37
Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Curr Pharm Des (2010) 1.37
Nonidentical subunits of p21H-ras farnesyltransferase. Peptide binding and farnesyl pyrophosphate carrier functions. J Biol Chem (1991) 1.36
Targeting of Rab GTPases to cellular membranes. Biochem Soc Trans (2005) 1.36
Endocervical cells in cervical smears. Am J Obstet Gynecol (1972) 1.36
Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: evidence from structure-activity relationships in J774 macrophages. J Bone Miner Res (1998) 1.36
Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone (2001) 1.35
The multinucleate cells in giant cell granulomas of the jaw are osteoclasts. Cancer (1988) 1.34
Evaluation of retinal photoreceptors and pigment epithelium in a female carrier of choroideremia. Ophthalmology (2001) 1.34
Crystallographically identical virus capsids display different properties in solution. Nat Struct Biol (1999) 1.33
Regulation and trafficking of three distinct 18 S ribosomal RNAs during development of the malaria parasite. J Mol Biol (1997) 1.33
Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology (2001) 1.32
A practical diagnostic test for choroideremia. Ophthalmology (1998) 1.32
Recognition of bases in Escherichia coli tRNA(Gln) by glutaminyl-tRNA synthetase: a complete identity set. EMBO J (1992) 1.31
The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis. Arthritis Rheum (2001) 1.31
Contact sensing in Candida albicans: a possible aid to epithelial penetration. J Med Vet Mycol (1992) 1.31
Bisphosphonates: pharmacology, mechanisms of action and clinical uses. Osteoporos Int (1999) 1.31
Vascular endothelial cell expression of ICAM-1 and VCAM-1 at the onset of eliciting contact hypersensitivity in mice: evidence for a dominant role of TNF-alpha. J Immunol (1999) 1.30
The pharmacology of bisphosphonates and new insights into their mechanisms of action. J Bone Miner Res (1999) 1.30
Prenylation of Rab GTPases: molecular mechanisms and involvement in genetic disease. FEBS Lett (2001) 1.29
Cell surface characterization of the human osteoclast: phenotypic relationship to other bone marrow-derived cell types. J Pathol (1984) 1.28
Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine (Baltimore) (1992) 1.25
Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates. Bone (2003) 1.24